期刊文献+

逆转录病毒载体表达的膜型免疫球蛋白介导B细胞受体细胞信号传导 被引量:1

原文传递
导出
摘要 B细胞的激活是通过B细胞受体与其特异性抗原的结合引起,并引发后续的信号级联反应.深入了解这一重要事件的分子机制是免疫学研究的重要目标.嵌合B细胞受体是B细胞信号功能研究的有效工具.然而,这一方法仅适用于工具细胞,不能被用于体内研究.本研究构建了能同时表达针对特异性抗原的膜型免疫球蛋白的重链和轻链的逆转录病毒载体,通过逆转录病毒载体将这一膜型免疫球蛋白表达在原始B淋巴细胞膜上.结果证实,通过逆转录病毒载体表达的膜型免疫球蛋白能引发B细胞受体的信号转导,可引发B细胞受体下游Syk和Erk1/2蛋白的磷酸化.本研究进一步表明,B淋巴细胞表达的膜型免疫球蛋白在体外和体内均能与特异性抗原结合并导致细胞增殖.因此,本研究提供了一个能在体外和体内快速方便地分析B细胞受体下游信号级联反应的方法,这一方法将有助于更深入地研究与B细胞功能相关的各种蛋白.
出处 《中国科学:生命科学》 CSCD 北大核心 2015年第9期860-870,共11页 Scientia Sinica(Vitae)
基金 国家重点基础研究发展计划(批准号:2011CB965203)资助项目
  • 相关文献

参考文献19

  • 1Niiro H, Clark E A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol, 2002, 2:945-956.
  • 2Reth M, Wienands J. Initiation and processing of signals from the B-cell antigen receptor. Annu Rev Immunol, 1997, 15:453-479.
  • 3Kurosaki T. Regulation of BCR signaling. Mol Immunol, 2011, 48:1287-1291.
  • 4Sanchez M, Misulovin Z, Burkhardt A L, et al. Signal transduction by immunoglobulin is mediated through Ig alpha and Ig beta. J Exp Med, 1993, 178:1049-1055.
  • 5Flaswinkel H, Reth M. Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO, 1994, 13:83-89.
  • 6Glimcher L H, Kim K J, Green I, et al. Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med, 1982, 155:445-459.
  • 7Justemen L B, Campbell K S, Chien N C, et al. Regulation of B cell antigen receptor signal transdnction and phosphorylation by CD45. Science, 1991, 252:1839-1842.
  • 8Ru W, Peijie C. Modulation of NKT cells and Thl/Th2 imbalance after alpha-GalCer treatment in progressive load-trained rats. Int J Biol Sci, 2009, 5:338-343.
  • 9Andersson J, Moiler G, Sjoberg O. Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol, 1972, 4:381-393.
  • 10Blomgren H, Svedmyr E. Evidence for thymic dependence of PHA-reactive cells in spleen and lymph nodes and independence in bone marrow. J Immunol, 1971, 106:835-845.

同被引文献23

  • 1Dykxhoorn D M,Lieberman J.Knocking down Disease with siRNAs.Cell,2006,126:231-235.
  • 2Butz K,Ristriani T,Hengstermann A,et al.siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells.Oncogene,2003,22:5938-5945.
  • 3Thomas C E,Ehrhardt A,Kay M A.Progress and problems with the use of viral vectors for gene therapy.Nat Rev Genet,2003,4:346-358.
  • 4Gao Y,Liu X L,Li X R.Research progress on siRNA delivery with nonviralcarriers.Int J Nanomedicine,2011,6:1017-1025.
  • 5Howard K A.Delivery of RNA interference therapeutics using polycation-based nanoparticles.Advanced Drug Delivery Rev,2009,61:710-720.
  • 6Swierczewska M,Han H S,Kim K,et al.Polysaccharide-based nanoparticles for theranostic nanomedicine.Advanced Drug Delivery Rev,2016,99:70-84.
  • 7Singh D,Han S S,Shin E J.Polysaccharides as Nanocarriers for Therapeutic Applications.j biomed nanotechnol,2014,10:2149-2172.
  • 8Ahmed T A,Aljaeid B M.Preparation,characterization,and potential applicationof chitosan,chitosan derivatives,and chitosan metal nanoparticles inpharmaceutical drug delivery.Drug Des Devel Ther,2016,10:483-507.
  • 9Singh R S,Kaur N,Kennedy J F.Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting.Carbohydrate Polymers,2015,123:190-207.
  • 10Ge C,Tian J,Zhao Y,et al.Towards understanding of nanoparticle-protein corona.Arch Toxicol,2015,89:519-539.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部